In a prospective investigation on the transfusion of blood to 209 patients,a distinct difference was found between the frequency of leuko-agglutinins and lymphocytotoxic antibodies in the sera of patients with reported febrile transfusion reactions and patients without. No such difference, however, was demonstrated concerning thrombocyte agglutinins and thrombocyte complement-fixing antibodies. A significant difference was found between the incidence of transfusion reactions in patients with leukocyte antibodies in their sera and in patients without. If sera from patients with reported transfusion reactions were matched against leukocytes and trombocytes of the respective donors, incompatibility was demonstrated in all cases. Minor incompatibility was found to be a most unlikely cause of transfusion reactions in this material. The results of our study are thus confirming the concept that leukocyte incompatibility is causually related to febrile transfusion reactions, whereas evidence concerning the influence of thrombocyte incompatibility still is too small to be conclusive.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.